Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
33.56
+0.09 (0.27%)
Aug 14, 2026, 4:00 PM EDT - Market closed

Agios Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-411.29-412.78673.73-352.09-231.81,605
Depreciation & Amortization
5.355.185.656.628.569.24
Loss (Gain) From Sale of Assets
-0.01-200.040.55-0.050.01
Loss (Gain) From Sale of Investments
-5.91-7.31-14.65-5.08-1.26.95
Stock-Based Compensation
57.9852.5542.8544.7749.353.51
Other Operating Activities
37.9122.43-877.6128.22-117.86-1,952
Change in Accounts Receivable
-19.23-6.47-1.3-0.6-2.21-
Change in Inventory
0.7-5.3-8.54-10.58-8.49-
Change in Accounts Payable
-1.251.756.6-8.733.441.86
Change in Income Taxes
--0.870.87---
Change in Other Net Operating Assets
-24.86-22.15-17.40.86-9.17-38.69
Operating Cash Flow
-360.6-372.98-389.84-296.06-309.48-407.32
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-4.66-4.32-1.69-1-4.88-5.74
Sale of Property, Plant & Equipment
--0.041.330.96-
Divestitures
--200---
Sale (Purchase) of Intangibles
-25-10--17.5--
Investment in Securities
396.81391.5-724.05256.75115.39-548.42
Other Investing Activities
--889.14-131.781,803
Investing Cash Flow
367.15377.18363.44239.58243.261,249

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
-----0.33-0.58
Net Debt Issued (Repaid)
-----0.33-0.58
Issuance of Common Stock
12.228.6814.445.432.6837.3
Repurchase of Common Stock
------802.49
Financing Cash Flow
12.228.6814.445.432.35-765.77

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
18.7812.88-11.96-51.05-63.8775.69

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-365.25-377.29-391.53-297.06-314.36-413.06
Free Cash Flow Growth
------
Free Cash Flow Margin
-371.42%-698.33%-1072.73%-1107.49%-2207.58%-
Free Cash Flow Per Share
-6.22-6.51-6.76-5.34-5.74-6.83
Levered Free Cash Flow
-274.6-267.97-222.83-215.06-195.32-198.29
Unlevered Free Cash Flow
-274.6-267.97-222.83-215.06-195.32-198.29

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
-0.6343.151.57-16.08
Change in Working Capital
-44.65-33.04-19.77-19.06-16.43-36.82
SEC Filings: 10-K · 10-Q